Functional and phenotypical alterations of polymorphonuclear cells in atopic dermatitis patients
Fierro Mt(University of Turin), Mg Bernengo(University of Turin), Daniela Scalas, Mauro Novelli(University of Turin), Annamaria Cuffini(University of Turin), Chiara Merlino, Pietro Quaglino(Department of Medical Sciences), Federica Marenco(University Dermatology), Valeria Allizond(Department of Public Health), Giuliana Banche(University of Turin)
Unknown
January 1, 2012
Cited by 0
Related Papers
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
|JAMA Dermatology|2015|452
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449